# A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolescents With Moderate to Severe Chronic Hand Eczema

> **NCT06004050** · PHASE3 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 362 (actual)

## Conditions studied

- Chronic Hand Eczema

## Interventions

- **DRUG:** Delgocitinib
- **OTHER:** Vehicle cream

## Key facts

- **NCT ID:** NCT06004050
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-05
- **Primary completion:** 2024-12-16
- **Final completion:** 2025-09-12
- **Target enrollment:** 362 (ACTUAL)
- **Last updated:** 2025-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06004050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06004050, "A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolescents With Moderate to Severe Chronic Hand Eczema". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06004050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*